about
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program.Diffuse large B-cell lymphoma in the elderly: a review of potential difficulties.Treatment approaches to asymptomatic follicular lymphoma.Body mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era.Chemotherapy-free treatment in patients with follicular lymphoma.The biology of aging and lymphoma: a complex interplay.Primary refractory diffuse large B cell lymphoma in the rituximab era.Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas.Outcome of older patients with acute myeloid leukemia in first relapse.Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient.Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index.Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSAThe translocation behind follicular lymphoma developmentRituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphomaComposite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases
P50
Q33412354-9ADEDAD1-AF54-4125-A483-8BB687AF05ACQ37216260-C5BCA2A4-4C8B-47BB-AE9A-5C96FF904F03Q38075871-A3557B0E-6A5A-44EB-9448-B73C791CB399Q38161963-360FDA85-E7DB-4960-A8AF-BDE282DFFE96Q38264354-5F3A437E-BFD1-4D72-8916-0AEC3042E935Q38317235-08249F8C-FFEF-48F0-A5AF-BC959F76711BQ38500035-1B258D71-50C1-462B-8BAE-32E83D747316Q38563655-F3704601-76B2-4FDF-B1A9-C697D4F000BCQ38627352-A1517278-4FC6-448D-B1C9-C65E3BD16A45Q39405204-E1312391-396C-4E14-ABD2-B66FB834C8ACQ39685534-C9D7E1FC-2FC8-43B4-8FD0-4398AF27888AQ40414752-360D3F47-6852-443F-8B51-CEBD9299806CQ44270926-7CDEF44A-99EF-43DD-8BE4-31A0010B9539Q46150655-BC61CCEF-84E5-4252-97E6-571D9F7A29EDQ47752514-0E26352E-8167-452A-9C3B-C9671B32E2E2Q52985309-8838ABC5-6171-4249-8060-500F9B99C5B2Q53099339-A92B0F63-054A-4948-8816-36CE514EDC6FQ53099728-1D1DFE95-0B5F-440C-B625-07CCA47DC5C1Q59048895-681CA421-0AA3-485B-BFBA-A8D290CA5120Q60195401-F10F6556-BD47-468C-A682-64490BB1F0BBQ60195404-8C5B6E94-3B9A-44D0-B036-B7CC35CF9856Q89587485-8075C21D-0790-46E9-97C4-561DF51889CE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clémentine Sarkozy
@ast
Clémentine Sarkozy
@en
Clémentine Sarkozy
@es
Clémentine Sarkozy
@nl
Clémentine Sarkozy
@sl
type
label
Clémentine Sarkozy
@ast
Clémentine Sarkozy
@en
Clémentine Sarkozy
@es
Clémentine Sarkozy
@nl
Clémentine Sarkozy
@sl
prefLabel
Clémentine Sarkozy
@ast
Clémentine Sarkozy
@en
Clémentine Sarkozy
@es
Clémentine Sarkozy
@nl
Clémentine Sarkozy
@sl
P106
P21
P31
P496
0000-0002-1942-9304